跳至主導覽 跳至搜尋 跳過主要內容

Sybil: A Validated Deep Learning Model to Predict Future Lung Cancer Risk from a Single Low-Dose Chest Computed Tomography

  • Peter G. Mikhael
  • , Jeremy Wohlwend
  • , Adam Yala
  • , Ludvig Karstens
  • , Justin Xiang
  • , Angelo K. Takigami
  • , Patrick P. Bourgouin
  • , Puiyee Chan
  • , Sofiane Mrah
  • , Wael Amayri
  • , Yu Hsiang Juan
  • , Cheng-Ta Yang
  • , Yung Liang Wan
  • , Gigin Lin
  • , Lecia V. Sequist*
  • , Florian J. Fintelmann
  • , Regina Barzilay
  • *此作品的通信作者
  • Massachusetts Institute of Technology
  • Harvard University
  • Massachusetts General Hospital
  • Chang Gung University
  • Chang Gung Memorial Hospital

研究成果: 期刊稿件 › 文章 › 同儕審查

275 引文 (SciVal)

摘要

PURPOSE: Low-dose computed tomography (LDCT) for lung cancer screening is effective, although most eligible people are not being screened. Tools that provide personalized future cancer risk assessment could focus approaches toward those most likely to benefit. We hypothesized that a deep learning model assessing the entire volumetric LDCT data could be built to predict individual risk without requiring additional demographic or clinical data.

METHODS: We developed a model called Sybil using LDCTs from the National Lung Screening Trial (NLST). Sybil requires only one LDCT and does not require clinical data or radiologist annotations; it can run in real time in the background on a radiology reading station. Sybil was validated on three independent data sets: a heldout set of 6,282 LDCTs from NLST participants, 8,821 LDCTs from Massachusetts General Hospital (MGH), and 12,280 LDCTs from Chang Gung Memorial Hospital (CGMH, which included people with a range of smoking history including nonsmokers).

RESULTS: Sybil achieved area under the receiver-operator curves for lung cancer prediction at 1 year of 0.92 (95% CI, 0.88 to 0.95) on NLST, 0.86 (95% CI, 0.82 to 0.90) on MGH, and 0.94 (95% CI, 0.91 to 1.00) on CGMH external validation sets. Concordance indices over 6 years were 0.75 (95% CI, 0.72 to 0.78), 0.81 (95% CI, 0.77 to 0.85), and 0.80 (95% CI, 0.75 to 0.86) for NLST, MGH, and CGMH, respectively.

CONCLUSION: Sybil can accurately predict an individual's future lung cancer risk from a single LDCT scan to further enable personalized screening. Future study is required to understand Sybil's clinical applications. Our model and annotations are publicly available.

UNLABELLED: [Media: see text].

原文英語
頁(從 - 到)2191-2200
頁數10
期刊Journal of Clinical Oncology
卷41
發行號12
DOIs
出版品狀態已出版 - 20 04 2023

文獻附註

Publisher Copyright:
© American Society of Clinical Oncology.

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Sybil: A Validated Deep Learning Model to Predict Future Lung Cancer Risk from a Single Low-Dose Chest Computed Tomography」主題。共同形成了獨特的指紋。

引用此